Heterozygote for plasmin inhibitor deficiency developing hemorrhagic tendency with advancing age.

[1]  P M Mannucci,et al.  Hypercoagulability in centenarians: the paradox of successful aging. , 1995, Blood.

[2]  K. High,et al.  Molecular Basis of Thrombosis and Hemostasis , 1995 .

[3]  T. Koyama,et al.  Different NH2-terminal form with 12 additional residues of alpha 2-plasmin inhibitor from human plasma and culture media of Hep G2 cells. , 1994, Biochemical and biophysical research communications.

[4]  B. Binder,et al.  Direct evidence for systemic fibrinogenolysis in patients with acquired α2‐plasmin inhibitor deficiency , 1994, American journal of hematology.

[5]  N. Aoki.  Clot Retraction Increases Clot Resistance to Fibrinolysis by Condensing α2-Plasmin Inhibitor Crosslinked to Fibrin , 1993, Thrombosis and Haemostasis.

[6]  A. Johnsen,et al.  Different N-terminal forms of α2-plasmin inhibitor in human plasma , 1993 .

[7]  O. Miura,et al.  Expression and characterization of pro alpha 2-plasmin inhibitor. , 1989, Journal of biochemistry.

[8]  N. Aoki.  Hemostasis associated with abnormalities of fibrinolysis. , 1989, Blood reviews.

[9]  F. Leebeek,et al.  Mild Haemostatic Problems Associated with Congenital Heterozygous α2-Antiplasmin Deficiency , 1988, Thrombosis and Haemostasis.

[10]  P. Vokonas,et al.  Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. , 1987, The Journal of clinical investigation.

[11]  C. Kluft,et al.  Influence of Factor Xllla Activity on Human Whole Blood Clot Lysis In Vitro , 1987, Thrombosis and Haemostasis.

[12]  J. Mimuro,et al.  Monoclonal antibodies to discrete regions in alpha 2-plasmin inhibitor. , 1987, Blood.

[13]  N. Aoki,et al.  Excessive fibrinolysis in suspected amyloidosis: Demonstration of plasmin‐α2‐plasmin inhibitor complex and von Willebrand factor fragment in plasma , 1986, American journal of hematology.

[14]  J. Amiral,et al.  Development and Performance Characteristics of a Competitive Enzyme Immunoassay for Fibrinopeptide A , 1984, Seminars in thrombosis and hemostasis.

[15]  Kaname. Nakamura,et al.  Selective determination of α2-plasmin inhibitor activity in plasma using chromogenic substrate , 1984 .

[16]  N. Aoki.  Genetic Abnormalities of the Fibrinolytic System , 1984, Seminars in thrombosis and hemostasis.

[17]  P. Harpel,et al.  Inhibitors of the Fibrinolytic Enzyme System , 1984, Seminars in thrombosis and hemostasis.

[18]  Y. Sakata,et al.  Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiency , 1983 .

[19]  P. Wallén,et al.  An Enzyme Linked Immunosorbent Assay for Determination of Tissue Plasminogen Activator Applied to Patients with Thromboembolic Disease , 1983, Thrombosis and Haemostasis.

[20]  G. Gogstad,et al.  Hereditary α2-antiplasmin deficiency , 1983 .

[21]  E. Vellenga,et al.  A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin. , 1982, Blood.

[22]  J. Griffin,et al.  A bleeding disorder due to deficiency of alpha 2-antiplasmin. , 1982, Blood.

[23]  Y. Sakata,et al.  Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. , 1982, The Journal of clinical investigation.

[24]  J. Conard,et al.  Modifications of α2-Plasmin Inhibitor During Treatments by a Defibrinating Agent , 1979, Thrombosis and Haemostasis.

[25]  Y. Sakata,et al.  Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency , 1979 .

[26]  O. Odegård,et al.  Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH). , 1977, Thrombosis research.

[27]  L. Lorand,et al.  Transamidating enzymes. II. A continuous fluorescent method suited for automating measurements of factor XIII in plasma. , 1971, Analytical biochemistry.

[28]  M. Blombäck,et al.  Nomenclature of Quantities and Units in Thrombosis and Haemostasis (Recommendation 1993) , 1994, Thrombosis and Haemostasis.

[29]  O. Miura,et al.  Human alpha 2-plasmin inhibitor. , 1993, Methods in enzymology.

[30]  A. Yoshioka,et al.  Congenital Deficiency of α2-Plasmin Inhibitor in Three Sisters , 1982 .

[31]  G. Claeson,et al.  Methods for the Determination of Plasmin, Antiplasmin and Plasminogen by Means of the Substrate S-2251 , 1977, Thrombosis and Haemostasis.